The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biopharmaceutical (biopharma) Blister Packaging-Global Market Insights and Sales Trends 2025
Synopsis
The global Biopharmaceutical (biopharma) Blister Packaging market size is expected to reach US$ 23310 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biopharmaceutical (biopharma) Blister Packaging in various end use industries. The expanding demands from the Capsule Drug, Tablets Drug and Others Drug,, are propelling Biopharmaceutical (biopharma) Blister Packaging market. PVC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lidding Foils segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharmaceutical (biopharma) Blister Packaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharmaceutical (biopharma) Blister Packaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharmaceutical (biopharma) Blister Packaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharmaceutical (biopharma) Blister Packaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharmaceutical (biopharma) Blister Packaging covered in this report include Bemis, MeadWestvaco Corp, Klöckner Pentaplast, Constantia Flexibles, Tekni-plex, Honeywell, Amcor, CPH Group and Bilcare, etc.
The global Biopharmaceutical (biopharma) Blister Packaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bemis
MeadWestvaco Corp
Klöckner Pentaplast
Constantia Flexibles
Tekni-plex
Honeywell
Amcor
CPH Group
Bilcare
Shanghai Haishun
Global Biopharmaceutical (biopharma) Blister Packaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharmaceutical (biopharma) Blister Packaging market, Segment by Type:
PVC
Lidding Foils
Cold Form
PVDC
Global Biopharmaceutical (biopharma) Blister Packaging market, by Application
Capsule Drug
Tablets Drug
Others Drug
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharmaceutical (biopharma) Blister Packaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biopharmaceutical (biopharma) Blister Packaging market size is expected to reach US$ 23310 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biopharmaceutical (biopharma) Blister Packaging in various end use industries. The expanding demands from the Capsule Drug, Tablets Drug and Others Drug,, are propelling Biopharmaceutical (biopharma) Blister Packaging market. PVC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lidding Foils segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharmaceutical (biopharma) Blister Packaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharmaceutical (biopharma) Blister Packaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharmaceutical (biopharma) Blister Packaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharmaceutical (biopharma) Blister Packaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharmaceutical (biopharma) Blister Packaging covered in this report include Bemis, MeadWestvaco Corp, Klöckner Pentaplast, Constantia Flexibles, Tekni-plex, Honeywell, Amcor, CPH Group and Bilcare, etc.
The global Biopharmaceutical (biopharma) Blister Packaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bemis
MeadWestvaco Corp
Klöckner Pentaplast
Constantia Flexibles
Tekni-plex
Honeywell
Amcor
CPH Group
Bilcare
Shanghai Haishun
Global Biopharmaceutical (biopharma) Blister Packaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharmaceutical (biopharma) Blister Packaging market, Segment by Type:
PVC
Lidding Foils
Cold Form
PVDC
Global Biopharmaceutical (biopharma) Blister Packaging market, by Application
Capsule Drug
Tablets Drug
Others Drug
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharmaceutical (biopharma) Blister Packaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biopharmaceutical (biopharma) Blister Packaging
1.1 Biopharmaceutical (biopharma) Blister Packaging Market Overview
1.1.1 Biopharmaceutical (biopharma) Blister Packaging Product Scope
1.1.2 Biopharmaceutical (biopharma) Blister Packaging Market Status and Outlook
1.2 Global Biopharmaceutical (biopharma) Blister Packaging Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biopharmaceutical (biopharma) Blister Packaging Market Size by Region (2018-2029)
1.4 Global Biopharmaceutical (biopharma) Blister Packaging Historic Market Size by Region (2018-2023)
1.5 Global Biopharmaceutical (biopharma) Blister Packaging Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biopharmaceutical (biopharma) Blister Packaging Market Size (2018-2029)
1.6.1 North America Biopharmaceutical (biopharma) Blister Packaging Market Size (2018-2029)
1.6.2 Europe Biopharmaceutical (biopharma) Blister Packaging Market Size (2018-2029)
1.6.3 Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Market Size (2018-2029)
1.6.4 Latin America Biopharmaceutical (biopharma) Blister Packaging Market Size (2018-2029)
1.6.5 Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Market Size (2018-2029)
2 Biopharmaceutical (biopharma) Blister Packaging Market by Type
2.1 Introduction
2.1.1 PVC
2.1.2 Lidding Foils
2.1.3 Cold Form
2.1.4 PVDC
2.2 Global Biopharmaceutical (biopharma) Blister Packaging Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Historic Market Size by Type (2018-2023)
2.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Type (2018-2029)
3 Biopharmaceutical (biopharma) Blister Packaging Market Overview by Application
3.1 Introduction
3.1.1 Capsule Drug
3.1.2 Tablets Drug
3.1.3 Others Drug
3.2 Global Biopharmaceutical (biopharma) Blister Packaging Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Historic Market Size by Application (2018-2023)
3.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biopharmaceutical (biopharma) Blister Packaging Revenue Breakdown by Application (2018-2029)
4 Biopharmaceutical (biopharma) Blister Packaging Competition Analysis by Players
4.1 Global Biopharmaceutical (biopharma) Blister Packaging Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharmaceutical (biopharma) Blister Packaging as of 2022)
4.3 Date of Key Players Enter into Biopharmaceutical (biopharma) Blister Packaging Market
4.4 Global Top Players Biopharmaceutical (biopharma) Blister Packaging Headquarters and Area Served
4.5 Key Players Biopharmaceutical (biopharma) Blister Packaging Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharmaceutical (biopharma) Blister Packaging Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bemis
5.1.1 Bemis Profile
5.1.2 Bemis Main Business
5.1.3 Bemis Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.1.4 Bemis Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.1.5 Bemis Recent Developments
5.2 MeadWestvaco Corp
5.2.1 MeadWestvaco Corp Profile
5.2.2 MeadWestvaco Corp Main Business
5.2.3 MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.2.4 MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.2.5 MeadWestvaco Corp Recent Developments
5.3 Klöckner Pentaplast
5.3.1 Klöckner Pentaplast Profile
5.3.2 Klöckner Pentaplast Main Business
5.3.3 Klöckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.3.4 Klöckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.3.5 Constantia Flexibles Recent Developments
5.4 Constantia Flexibles
5.4.1 Constantia Flexibles Profile
5.4.2 Constantia Flexibles Main Business
5.4.3 Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.4.4 Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.4.5 Constantia Flexibles Recent Developments
5.5 Tekni-plex
5.5.1 Tekni-plex Profile
5.5.2 Tekni-plex Main Business
5.5.3 Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.5.4 Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.5.5 Tekni-plex Recent Developments
5.6 Honeywell
5.6.1 Honeywell Profile
5.6.2 Honeywell Main Business
5.6.3 Honeywell Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.6.4 Honeywell Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.6.5 Honeywell Recent Developments
5.7 Amcor
5.7.1 Amcor Profile
5.7.2 Amcor Main Business
5.7.3 Amcor Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.7.4 Amcor Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.7.5 Amcor Recent Developments
5.8 CPH Group
5.8.1 CPH Group Profile
5.8.2 CPH Group Main Business
5.8.3 CPH Group Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.8.4 CPH Group Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.8.5 CPH Group Recent Developments
5.9 Bilcare
5.9.1 Bilcare Profile
5.9.2 Bilcare Main Business
5.9.3 Bilcare Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.9.4 Bilcare Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.9.5 Bilcare Recent Developments
5.10 Shanghai Haishun
5.10.1 Shanghai Haishun Profile
5.10.2 Shanghai Haishun Main Business
5.10.3 Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
5.10.4 Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2018-2023)
5.10.5 Shanghai Haishun Recent Developments
6 North America
6.1 North America Biopharmaceutical (biopharma) Blister Packaging Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biopharmaceutical (biopharma) Blister Packaging Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biopharmaceutical (biopharma) Blister Packaging Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biopharmaceutical (biopharma) Blister Packaging Market Dynamics
11.1 Biopharmaceutical (biopharma) Blister Packaging Industry Trends
11.2 Biopharmaceutical (biopharma) Blister Packaging Market Drivers
11.3 Biopharmaceutical (biopharma) Blister Packaging Market Challenges
11.4 Biopharmaceutical (biopharma) Blister Packaging Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
